RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to Corporate Advisory Board

RetinalGeniX? Technologies Inc. announced the appointment of Stephen Tannenbaum to the RetinalGeniX Advisory Board. Mr. Tannenbaum will provide strategic advice, opinions on potential mergers and acquisitions and the development of channels to acquire additional capital for the Company.

Mr. Tannenbaum is a seasoned capital markets professional with a proven track record of raising equity and debt capital for public and private companies in special situations. His expertise lies in crafting compelling narratives for capital raises and using resources and insights to deliver strategic, actionable advice. As a versatile generalist, he has successfully advised on and closed transactions across a variety of industries, including but not limited to technology, pharmaceuticals and cannabis.

Throughout his career as an investment banker, he has played an integral role in raising capital for M&A, equity and debt capital markets, IPOs and SPACs, focusing on specializing in the pharmaceutical and cannabis sectors. He graduated with honors from the Wharton School of the University of Pennsylvania, bringing a unique blend of academic excellence and real-world financial acumen.